| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | President And CEO
1 company
McCarthy Sean A. is a CEO at CytomX Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $3.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2021 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 100,000 | $7.49 | $749,470.00 | -32.6% | -16.3% | -65.5% | |
| May 12, 2020 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 36,000 | $15.00 | $540,000.00 | -29.9% | - | - | |
| Nov 2, 2018 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 6,526 | $15.00 | $97,898.59 | -2.5% | - | - | |
| Sep 4, 2018 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 13,052 | $21.86 | $285,342.82 | -13.7% | - | - | |
| Jul 5, 2018 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 4,497 | $25.06 | $112,688.52 | -5.2% | - | - | |
| Jul 3, 2018 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 2,028 | $25.09 | $50,880.49 | -2.4% | - | - | |
| Jul 2, 2018 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 13,052 | $23.42 | $305,707.86 | -13.7% | - | - | |
| May 1, 2018 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 19,578 | $26.55 | $519,743.04 | -80.8% | - | - | |
| Mar 1, 2018 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 19,578 | $29.43 | $576,141.38 | -80.8% | - | - | |
| Jan 5, 2018 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 6,526 | $25.01 | $163,215.26 | -58.4% | - | - |